+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Transdermal Patches Market by Product, Type, Technology, Application, Distribution Channel, End Users - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 183 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5519528
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Transdermal Patches Market grew from USD 8.57 billion in 2023 to USD 9.89 billion in 2024. It is expected to continue growing at a CAGR of 16.40%, reaching USD 24.84 billion by 2030.

Transdermal patches are a non-invasive method of delivering drugs through the skin, providing controlled and steady release into the bloodstream. The necessity of transdermal patches stems from the need for convenient drug administration options that bypass the gastrointestinal tract, reduce side effects, and maintain desired drug levels in systemic circulation. Their application spans various therapeutic areas including pain management, hormone replacement, nicotine cessation, and chronic conditions like cardiovascular diseases and Parkinson’s disease. The end-use scope largely encompasses the healthcare sector, including hospitals, clinics, and home healthcare settings.

The market for transdermal patches is influenced by increasing R&D efforts, growing prevalence of chronic diseases, and advancements in patch technologies that enhance drug delivery efficiency. Additionally, the aging population and rising demand for non-invasive drug delivery systems drive market growth. Latest opportunities arise in developing patches for new drug categories such as biologics and vaccines, with prospects for collaboration between pharmaceutical companies and technology firms to enhance patch design and delivery mechanisms. However, market growth is challenged by limitations such as skin irritation, limited permeability for large-molecule drugs, and regulatory hurdles relating to safety and efficacy.

Opportunities for innovation include exploring biocompatible and responsive materials that adjust to physiological conditions, integrating micro-needles to enhance permeability, and employing smart technology for real-time monitoring of drug release. These innovations could maximize patient compliance and therapeutic outcomes. The market is characterized by a competitive yet collaborative landscape with a focus on technological integration and expanded drug portfolios. Key recommendations for players in this field include investing in cross-disciplinary R&D to overcome permeability challenges, adhering to strict regulatory standards, and educating healthcare professionals and patients about the benefits of transdermal systems. Companies should also explore forming strategic partnerships to leverage technological advancements and scale market reach effectively.

Understanding Market Dynamics in the Transdermal Patches Market

The Transdermal Patches Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increased use of transdermal patches to treat chronic conditions worldwide
    • Rising preference for controlled drug release and non-invasive drug delivery solutions
    • Growing number of government approvals for transdermal patches
  • Market Restraints
    • High costs associated with transdermal patches
  • Market Opportunities
    • Ongoing research and development for advanced and highly efficient transdermal drug delivery patches
    • Emerging advances in the formulation and manufacturing of transdermal patches
  • Market Challenges
    • Limitations associated with transdermal drugs along with product recalls

Exploring Porter’s Five Forces for the Transdermal Patches Market

Porter’s Five Forces framework further strengthens the insights of the Transdermal Patches Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Transdermal Patches Market

External macro-environmental factors deeply influence the performance of the Transdermal Patches Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Transdermal Patches Market

The Transdermal Patches Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Transdermal Patches Market

The Transdermal Patches Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Key Company Profiles

The report delves into recent significant developments in the Transdermal Patches Market, highlighting leading vendors and their innovative profiles. These include Novartis AG, Luye Pharma Group Ltd, Gedeon Richter Plc, Johnson & Johnson Services, Inc., AbbVie Inc., Teva Pharmaceutical Industries Ltd., DifGen Pharmaceuticals LLC, Zydus Group, Bliss GVS Pharma Ltd., Sparsha Pharma International Pvt Ltd, GlaxoSmithKline Plc, LAVIPHARM GROUP HOLDING S.A., Purdue Pharma L.P., Nitto Denko Corporation, UCB S.A., Corsair Pharma, Inc., Amneal Pharmaceuticals, Inc., Tesa SE by Beiersdorf AG, Medherant Limited, ALVOGEN, AdhexPharma SAS, Tapemark by LTS Lohmann Therapie-Systeme AG, Icure Pharmaceutical Inc., ProSolus, Inc., Corium, Inc., Viatris Inc., Boehringer Ingelheim International GmbH, Endo International plc, BioNxt Solutions Inc., Bayer AG, Nutriband Inc, Teikoku Seiyaku Co., Ltd., Perrigo Company plc, and Noven Pharmaceuticals, Inc. by Hisamitsu Pharmaceutical Co., Inc..

Market Segmentation & Coverage

This research report categorizes the Transdermal Patches Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Matrix
    • Multi-layer Drug-in-Adhesive
    • Reservoir
    • Single-layer Drug-in-Adhesive
  • Type
    • Buprenorphine Transdermal Patch
    • Clonidine Transdermal Patch
    • Fentanyl Transdermal Patch
    • Nicotine Transdermal Patch
    • Oxybutynin Transdermal Patch
  • Technology
    • Chemical Enhancers
    • Electric Current
    • Mechanical Arrays
    • Thermal Ablation
  • Application
    • Hormonal Therapy
    • Overactive Bladder
    • Pain Relief
    • Smoking Reduction & Cessation Aid
  • Distribution Channel
    • Offline
    • Online
  • End Users
    • Clinics
    • Home Care Settings
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increased use of transdermal patches to treat chronic conditions worldwide
5.1.1.2. Rising preference for controlled drug release and non-invasive drug delivery solutions
5.1.1.3. Growing number of government approvals for transdermal patches
5.1.2. Restraints
5.1.2.1. High costs associated with transdermal patches
5.1.3. Opportunities
5.1.3.1. Ongoing research and development for advanced and highly efficient transdermal drug delivery patches
5.1.3.2. Emerging advances in the formulation and manufacturing of transdermal patches
5.1.4. Challenges
5.1.4.1. Limitations associated with transdermal drugs along with product recalls
5.2. Market Segmentation Analysis
5.2.1. Product: Significant penetration of Multi-layer Drug-in-Adhesive patches
5.2.2. Type: Extensive requirement for nicotine transdermal patches
5.2.3. Technology: Utilization of chemical enhancers to improve transdermal patch efficacy
5.2.4. Application: Expanding use of transdermal patches for hormonal therapy
5.2.5. Distribution Channel: Proliferation of transdermal patches on eCommerce platforms
5.2.6. End Users: Increasing prescription of transdermal patches in hospitals
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Transdermal Patches Market, by Product
6.1. Introduction
6.2. Matrix
6.3. Multi-layer Drug-in-Adhesive
6.4. Reservoir
6.5. Single-layer Drug-in-Adhesive
7. Transdermal Patches Market, by Type
7.1. Introduction
7.2. Buprenorphine Transdermal Patch
7.3. Clonidine Transdermal Patch
7.4. Fentanyl Transdermal Patch
7.5. Nicotine Transdermal Patch
7.6. Oxybutynin Transdermal Patch
8. Transdermal Patches Market, by Technology
8.1. Introduction
8.2. Chemical Enhancers
8.3. Electric Current
8.4. Mechanical Arrays
8.5. Thermal Ablation
9. Transdermal Patches Market, by Application
9.1. Introduction
9.2. Hormonal Therapy
9.3. Overactive Bladder
9.4. Pain Relief
9.5. Smoking Reduction & Cessation Aid
10. Transdermal Patches Market, by Distribution Channel
10.1. Introduction
10.2. Offline
10.3. Online
11. Transdermal Patches Market, by End Users
11.1. Introduction
11.2. Clinics
11.3. Home Care Settings
11.4. Hospitals
12. Americas Transdermal Patches Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Transdermal Patches Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Transdermal Patches Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. Market Share Analysis, 2023
15.2. FPNV Positioning Matrix, 2023
15.3. Competitive Scenario Analysis
15.3.1. DifGen Pharmaceuticals Launches A Second Product - Buprenorphine Transdermal System From Its U.S. Manufacturing Site Aveva Drug Delivery Systems; Expanding Its Portfolio Of Manufacturing & Marketing U.S. Made Transdermal Patches And Sublingual Films
15.3.2. Luye Pharma Ltd Launches New Alzheimer's Treatment In The UK
15.3.3. Corsair Pharma Announces USD 23 Million Series B Financing to Advance Clinical Trials in Pulmonary Arterial Hypertension
15.3.4. Vaxess Raises USD 9 Million to Accelerate mRNA Vaccine Patch Development
15.3.5. Almirall Acquires Rights To Distribute Alzheimer’s Treatment In Spain For An Initial EUR 45 Million
15.3.6. Corium and Lotus Pharmaceutical Enter into Exclusive License Agreement for Innovative Alzheimer's Disease Treatment ADLARITY in Multiple Markets Across Asia
15.3.7. Dexmedetomidine Transdermal Patch Fast Tracked for Postop Pain Management
15.3.8. LTS Completes its Entry into Large Molecule Drug Delivery with the Acquisition of the Sorrel Wearable Injection Device Business
15.3.9. BioNxt Receives Approval for European Clinical Study of Transdermal Rotigotine Patch for Parkinson’s Disease
15.3.10. Bionxt Signs Clinical Study Agreement and Commences Manufacture of Clinical Samples for Study of Transdermal Rotigotine Patch for Parkinson’s Disease
15.3.11. LTS Lohmann Leads Investment in Needle-Free Delivery Specialist
15.3.12. The Addition of Tesa Labtec GmbH Marks a Cornerstone in AdhexPharma’s Growth Path
List of Figures
FIGURE 1. TRANSDERMAL PATCHES MARKET RESEARCH PROCESS
FIGURE 2. TRANSDERMAL PATCHES MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 11. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 13. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 15. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2023 VS 2030 (%)
FIGURE 17. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 21. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 26. TRANSDERMAL PATCHES MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 27. TRANSDERMAL PATCHES MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. TRANSDERMAL PATCHES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. TRANSDERMAL PATCHES MARKET DYNAMICS
TABLE 7. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MULTI-LAYER DRUG-IN-ADHESIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY RESERVOIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY SINGLE-LAYER DRUG-IN-ADHESIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY BUPRENORPHINE TRANSDERMAL PATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CLONIDINE TRANSDERMAL PATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY FENTANYL TRANSDERMAL PATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY NICOTINE TRANSDERMAL PATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY OXYBUTYNIN TRANSDERMAL PATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CHEMICAL ENHANCERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY ELECTRIC CURRENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MECHANICAL ARRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY THERMAL ABLATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY HORMONAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY OVERACTIVE BLADDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PAIN RELIEF, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY SMOKING REDUCTION & CESSATION AID, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 54. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 55. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 56. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 57. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 59. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 60. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 61. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 62. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 63. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 65. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 76. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 78. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 80. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 81. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 82. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 83. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 85. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 86. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 87. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 89. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 91. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 92. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 93. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 95. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 98. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 101. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 103. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 104. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 105. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 106. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 107. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 109. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 110. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 111. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 113. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 115. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 116. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 117. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 118. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 119. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 122. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 123. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 125. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 127. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 128. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 129. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 130. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 131. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 133. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 134. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 135. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 136. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 137. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 139. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 140. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 141. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 142. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 143. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 146. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 147. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 148. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 149. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 151. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 159. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 160. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 161. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 162. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 164. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 165. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 166. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 167. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 168. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 170. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 171. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 172. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 173. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 174. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 176. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 177. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 178. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 179. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 180. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 182. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 183. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 184. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 185. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 186. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 188. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 189. ISRAEL TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 190. ISRAEL TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 191. ISRAEL TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 192. ISRAEL TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. ISRAEL TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 194. ISRAEL TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 195. ITALY TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 196. ITALY TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 197. ITALY TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 198. ITALY TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. ITALY TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 200. ITALY TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 202. NETHERLANDS TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 203. NETHERLANDS TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 204. NETHERLANDS TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 205. NETHERLANDS TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 206. NETHERLANDS TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 208. NIGERIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 213. NORWAY TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 214. NORWAY TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 215. NORWAY TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 216. NORWAY TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 217. NORWAY TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 218. NORWAY TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 219. POLAND TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 220. POLAND TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 221. POLAND TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 222. POLAND TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. POLAND TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 224. POLAND TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 225. QATAR TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 226. QATAR TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 227. QATAR TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 228. QATAR TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. QATAR TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 230. QATAR TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 231. RUSSIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 232. RUSSIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 233. RUSSIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 234. RUSSIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. RUSSIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 236. RUSSIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 238. SAUDI ARABIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 240. SAUDI ARABIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 242. SAUDI ARABIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 244. SOUTH AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 246. SOUTH AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 248. SOUTH AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 249. SPAIN TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 250. SPAIN TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 251. SPAIN TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 252. SPAIN TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 253. SPAIN TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 254. SPAIN TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 255. SWEDEN TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 256. SWEDEN TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 257. SWEDEN TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 258. SWEDEN TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 259. SWEDEN TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 260. SWEDEN TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 264. SWITZERLAND TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 265. SWITZERLAND TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 266. SWITZERLAND TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 267. TURKEY TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 268. TURKEY TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 269. TURKEY TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 270. TURKEY TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 271. TURKEY TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 272. TURKEY TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 280. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 282. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 284. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 285. TRANSDERMAL PATCHES MARKET SHARE, BY KEY PLAYER, 2023
TABLE 286. TRANSDERMAL PATCHES MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Transdermal Patches Market, which are profiled in this report, include:
  • Novartis AG
  • Luye Pharma Group Ltd
  • Gedeon Richter Plc
  • Johnson & Johnson Services, Inc.
  • AbbVie Inc.
  • Teva Pharmaceutical Industries Ltd.
  • DifGen Pharmaceuticals LLC
  • Zydus Group
  • Bliss GVS Pharma Ltd.
  • Sparsha Pharma International Pvt Ltd
  • GlaxoSmithKline Plc
  • LAVIPHARM GROUP HOLDING S.A.
  • Purdue Pharma L.P.
  • Nitto Denko Corporation
  • UCB S.A.
  • Corsair Pharma, Inc.
  • Amneal Pharmaceuticals, Inc.
  • Tesa SE by Beiersdorf AG
  • Medherant Limited
  • ALVOGEN
  • AdhexPharma SAS
  • Tapemark by LTS Lohmann Therapie-Systeme AG
  • Icure Pharmaceutical Inc.
  • ProSolus, Inc.
  • Corium, Inc.
  • Viatris Inc.
  • Boehringer Ingelheim International GmbH
  • Endo International plc
  • BioNxt Solutions Inc.
  • Bayer AG
  • Nutriband Inc
  • Teikoku Seiyaku Co., Ltd.
  • Perrigo Company plc
  • Noven Pharmaceuticals, Inc. by Hisamitsu Pharmaceutical Co., Inc.

Methodology

Loading
LOADING...

Table Information